Survival benefit and biomarker analysis of pyrotinib or pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer: a pooled analysis of two phase I studies

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2050-7771
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Survival benefit and biomarker analysis of pyrotinib or pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer: a pooled analysis of two phase I studies ; volume:11 ; number:1 ; day:20 ; month:2 ; year:2023 ; pages:1-10 ; date:12.2023
Biomarker Research ; 11, Heft 1 (20.2.2023), 1-10, 12.2023

Creator
Guan, Xiuwen
Ma, Fei
Li, Qiao
Chen, Shanshan
Lan, Bo
Fan, Ying
Wang, Jiayu
Luo, Yang
Cai, Ruigang
Zhang, Pin
Li, Qing
Xu, Binghe
Contributor
SpringerLink (Online service)

DOI
10.1186/s40364-023-00453-0
URN
urn:nbn:de:101:1-2023042621284333607734
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:55 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Associated

  • Guan, Xiuwen
  • Ma, Fei
  • Li, Qiao
  • Chen, Shanshan
  • Lan, Bo
  • Fan, Ying
  • Wang, Jiayu
  • Luo, Yang
  • Cai, Ruigang
  • Zhang, Pin
  • Li, Qing
  • Xu, Binghe
  • SpringerLink (Online service)

Other Objects (12)